federal_register: 2024-04840
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04840 | Labeling Requirements for Approved or Conditionally Approved New Animal Drugs | Proposed Rule | The Food and Drug Administration (FDA) is proposing to revise the requirements for the content and format of labeling for approved or conditionally approved new animal drugs to provide for a more comprehensive set of requirements in one location in the Code of the Federal Register (CFR). As part of this revision, certain current requirements would be updated and moved, and certain obsolete requirements would be removed. The proposed requirements would apply to the labeling of prescription and over-the-counter (OTC) new animal drugs, as well as new animal drugs for use in animal feeds. | 2024-03-12 | 2024 | 3 | https://www.federalregister.gov/documents/2024/03/12/2024-04840/labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs | https://www.govinfo.gov/content/pkg/FR-2024-03-12/pdf/2024-04840.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is proposing to revise the requirements for the content and format of labeling for approved or conditionally approved new animal drugs to provide for a more comprehensive set of requirements in one location in the... |